Baxter International Net Income

The latest net income for BAX is $-970M as of June 2026. That compares with $220M in the prior-year period — down 533.0% year over year. That is below the Healthcare sector average of $17B. Investors often review this figure alongside Baxter International's historical trend and sector peers before judging valuation or financial health.

Over the past year, BAX's net income moved from $220M to $-970M — a 533.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Baxter International's operating scale or balance-sheet position.

Against Healthcare companies, BAX currently prints $-970M for net income, while the sector average sits near $17B. That is roughly 105.9% below the sector mean. Large gaps often invite a closer look at Baxter International's growth, margins, and balance sheet.

A net income figure of $-970M for BAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $17B. Explore the charts below for those layers of context.

After noting BAX's net income ($-970M), review year-over-year change from $220M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.